1. Company Report 2018/11/28
Alex Huang

2. Leading Manufacturer from Taiwan
Our Milestone
Leading Manufacturer from Taiwan
BIOTEQUE is a leading Medical Device Manufacturer focusing on the disposable of treatment for Hemo-dialysis, Interventional Radiology, Urology, Cardio-vascular and ICU. Bioteque also provides OEM service.
Based on the competence of injection, extrusion, welding and quality assurance, Bioteque produces catheters, tubing, bags, and components, catheter related peripheral and accessories.
Located in Taiwan, Bioteque was founded in 1991 and went to public in Taipei's Stock Exchange Market in 2002

3. Company Profile Product
Dehp-Free Blood Line, AVF Needle, IV Bag, and Catheters
and peripherals for IR, Urology, Cardiovascular, and ICU. .
Capital
USD Mil. Public in TaiEx since 2001
Turnover
USD 45.5 Mil. (2016)
Quality
Certified
GMP by TFDA (TWN), ISO-9001,ISO by DNV, All Product Certified by CE Mark, Certain Products Cleared by FDA510(k)
Man Pwr/ Ocp
500 / 14,820 m2 (TW) ; 300/ 34, 288m2 (BMPI)
Com-
petence
100,000 Grade Clean Room, Injection, Extrusion, Mold creation, Bag HF Making, Automation, R&D
Machinery
Injector 21(TW) , 28(BMPI) ; Extruder 10 (TW), 4 (BMPI);
ETO Chamber 3 (TW), 3(BMPI); Assembly Automation 20
Honor
National Quality Award of Taiwan in 2013

4. Overview of Plant in Yi-Lan
Site Area ： 14,820m2

5. Deployment in ASEAN
BMPI, Bioteq Medical Phil. Inc., established in 2013, is 100% owned by Bioteque Corporation.
BMPI is focusing on manufacturing in Bloodline tubing for hemodialysis. More products will be introduced to BMPI within large spare space in future.
Location: PEZA Hermosa, Bataan
Operation: since 2014
Man Power: more than 400 employees
Site Area : 34, 288m2

6. BMPI Overview Chemical Storage Area EO Sterilization Area
Production A, E
& Warehouse

7. Comparison of Product five-year operating income
Unit: NT $ thousand

8. Comparison of Sales by Product

9. Comparison of sales area by product
Area/year
2016
2017
Q1~Q3,2018
Taiwan
27.75%
22.89%
20.18%
China
11.88%
10.37%
11.61%
Asia
14.60%
29.43%
27.79%
America
21.52%
20.60%
23.11%
Europe
11.87%
8.95%
10.18%
Africa
12.37%
7.75%
7.12%
Total
100.00%

10. Comparison of consolidated revenues from 2010 to 2018

11. Comparison of basic EPS of consolidated companies from 2010 to 2018

12. Gross margin comparison of consolidated companies

13. Gross profit margin analysis for Q3,2018
Compared with that in the second quarter of 2018, the gross profit margin of Bioteque in the 3rd quarter fell 1%. It mainly due to the category bloodline increases ,therefore gross profit slightly declines.
The gross profit of sales in the past three years shifts from 44% to 42%, mainly due to the increase in raw material costs and labor costs.
To increase profit of the company, Bioteque Corp. keeps on developing and promoting high-end medical disposable products .

14. Market Risk-Currency risk
Period
2017/1/1~2017/9/30
2016/1/1~2016/9/30
1% depreciation of the NTD against the foreign currencies
The net profit after tax increased NTD3,785,000
The net profit after tax increased NTD 5,407,000
1% appreciation of the NTD against the foreign currencies
The net profit after tax decreased NTD3,785,000
The net profit after tax decreased NTD5,407,000
Foreign exchange gains (losses)
Gains NTD 6,336,000
Losses NTD 30,848,000

15. Thank you
Merci